Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolysis, anticoagulation, and reocclusion.

E Rapaport1

  • 1Department of Medicine, University of California, San Francisco.

The American Journal of Cardiology
|December 5, 1991
PubMed
Summary

Higher recanalization rates with alteplase did not reduce early mortality in acute myocardial infarction patients compared to streptokinase. Prolonged systemic fibrinolysis may reduce reocclusion, improving thrombolytic therapy efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines for the acute coronary syndromes.

Current cardiology reports·2001
Same author

Erythrocyte sedimentation rate: is it a useful risk marker for coronary heart disease?

European heart journal·2000
Same author

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Journal of the American College of Cardiology·1999
Same author

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Circulation·1999
Same author

Mapping of HIV-1 determinants of apoptosis in infected T cells.

Virology·1999
Same author

Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates.

Proceedings of the National Academy of Sciences of the United States of America·1998

Area of Science:

  • Cardiology
  • Pharmacology
  • Thrombosis Research

Background:

  • Acute myocardial infarction (AMI) treatment often involves thrombolytic agents.
  • Alteplase was favored over streptokinase due to higher recanalization rates, presumed to lower mortality.
  • Previous studies suggested alteplase's superiority in reperfusion and mortality reduction.

Purpose of the Study:

  • To evaluate the correlation between infarct-related artery recanalization rates and early hospital mortality in AMI patients.
  • To compare the efficacy of thrombolytic agents with varying clot specificities and systemic effects on mortality and reocclusion.

Main Methods:

  • Analysis of data from large-scale clinical trials like Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI-2).
  • Comparison of 15-day mortality rates between patients treated with different thrombolytic agents (e.g., alteplase vs. streptokinase).
  • Assessment of factors influencing thrombolytic efficacy, including early reocclusion and systemic fibrinolytic state.

Main Results:

  • No significant difference in 15-day mortality was observed between alteplase and streptokinase in over 20,000 AMI patients.
  • Higher recanalization rates with alteplase did not translate to reduced early mortality.
  • Early reocclusion was identified as a critical factor limiting the clinical benefit of thrombolytic drugs.

Conclusions:

  • Reperfusion rates alone do not fully predict early mortality reduction in AMI.
  • A prolonged systemic fibrinolytic state, potentially induced by agents like streptokinase, may be advantageous in reducing rethrombosis.
  • Thrombolytic strategies should consider the balance between recanalization and reocclusion to optimize clinical outcomes.

Related Experiment Videos